Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


Iroquois Capital Management, LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 SC 13D/A Iroquois Capital Management, LLC reports a 5% stake in PharmaCyte Biotech, Inc.
05/12/2023 SC 13D/A Iroquois Capital Management, LLC reports a 7% stake in PharmaCyte Biotech, Inc.
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Iroquois Capital Management, LLC reports a 6.5% stake in MyMD Pharmaceuticals, Inc.
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/15/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/28/2022 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
07/26/2022 PREC14A Form PREC14A - Preliminary proxy statements, contested solicitations:
07/15/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/11/2022 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
07/11/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/05/2022 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
06/23/2022 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
06/23/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/23/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/23/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/23/2022 SC 13G/A Iroquois Capital Management, LLC reports a 9.6% stake in MyMD Pharmaceuticals, Inc.
02/23/2022 SC 13G/A Iroquois Capital Management, LLC reports a 1.9% stake in Synthetic Biologics, Inc.
02/23/2022 SC 13G/A Iroquois Capital Management, LLC reports a 3.8% stake in Oblong, Inc.
02/23/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/23/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/23/2022 SC 13G/A Iroquois Capital Management, LLC reports a 5% stake in Petros Pharmaceuticals, Inc.
11/04/2021 SC 13D Iroquois Capital Management, LLC reports a 5.1% stake in PharmaCyte Biotech, Inc.
10/22/2021 SC 13G Iroquois Capital Management, LLC reports a 10% stake in Petros Pharmaceuticals, Inc.
09/21/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/18/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/22/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/22/2021 SC 13G/A Iroquois Capital Management, LLC reports a 10% stake in AKERS BIOSCIENCES, INC.
02/22/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/22/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/22/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/03/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/04/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/15/2020 SC 13G Iroquois Capital Management, LLC reports a 7.6% stake in Oblong, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy